Ad
related to: pfizer stock price today
Search results
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Investor's Business Daily· 5 hours agoBenefits For Regenxbio, Solid But most analysts didn't consider Pfizer a serious competitor. "The...
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 12 hours agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 4 days agoThe Zacks Value Style Score...than a C; and so on), is pretty helpful in identifying whether a stock...
Thinking Of Buying Pfizer For Its 5.8% Dividend Yield? Consider This Alternative Option Instead
Benzinga via Yahoo Finance· 6 days agoPfizer Inc. (NYSE:PFE) has long been a favorite among income investors, thanks to its generous...
Health Care Roundup: Market Talk
The Wall Street Journal· 9 hours agoCiti thinks this development has been reflected in WuXi AppTec’s share-price surge on Wednesday but “second-day profit taking” could weigh on the...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 6 days agoAnd right now, it yields 5.4%. That's even as the stock has soared more than 40% this year. Organon...
Indexes Close Near Session Highs, But Small Caps Struggle; Tesla Pares Gains (Live Coverage)
Investor's Business Daily· 5 hours agoThe Dow Jones fell slightly but other indexes rose to record highs after inflation data. Tesla...
Here's Why Eli Lilly Will Likely Announce a Stock Split
247wallst.com· 2 days agoWith its stock price fast approaching $1000 per share, drugmaker Eli lilly is poised for a forward ...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 3 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
